Issue 9, 2024

Correction: Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity

Abstract

Correction for ‘Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity’ by Keqin Ji et al., Biomater. Sci., 2022, 10, 702–713, https://doi.org/10.1039/D1BM01663F.

Associated articles

Article information

Article type
Correction
Submitted
04 Apr 2024
Accepted
04 Apr 2024
First published
11 Apr 2024
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2024,12, 2446-2447

Correction: Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity

K. Ji, M. Fan, D. Huang, L. Sun, B. Li, R. Xu, J. Zhang, X. Shao and Y. Chen, Biomater. Sci., 2024, 12, 2446 DOI: 10.1039/D4BM90028F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements